Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value

Journal of Clinical Pathology

Volumn 60, Issue 6, 2007, Pages 670-673

  Langguth, Daman M ^a,b   Morris, Samantha ^c   Clifford, Lynette ^b   Wilson, Robert J ^c   Neil, John ^c   Hogan, Patrick G ^b   Wong, Richard C W ^c  

^a Sullivan Nicolaides Pathology   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RO ANTIBODY;

ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SCHIRMER TEST; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MASS SCREENING; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME; UNNECESSARY PROCEDURES;

EID: 34250849065     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.040360     Document Type: Article

References (11)

1. Fronceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005;38:55-63.
2. Peene I, Meheus L, De Keyser S, et al. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 2002;61:929-33.
3. McCauliffe DP, Wang L, Satoh M, et al. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol 1997;24:860-6.
4. Miranda-Carus ME, Boutjdir M, Tseng CE, et al. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 1998;161:5886-92.
5. Gordon P, Rosenthal E, Simpson JM, et al. Anti-52 kDa Ro, anfi-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004;31:2480-7.
6. Rutjes SA, Vree-Egberts WT, Jongen P, et al. Anti-Ro52 antibodies frequently cooccur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997;109:32-40.
7. Collins RJ, Neil JC, Druery UN, et al. Detection of antibodies to extractable nuclear antigens using calf thymus and rabbit thymus. A comparative study of 1000 consecutive anti-nuclear antibody positive patients. J Immunol Methods 1989;116:53-7.
8. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
9. Lopez-Longo FJ, Rodriguez-Mahou M, Escalona-Monge M, et al. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003;12:623-9.
10. Keech CL, McCluskey J, Gordon TP. Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells. Clin Immunol Immunopathol 1994;73:146-51.
11. Frank MB, McCubbin V, Trieu E, et al. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 1999;12:137-42.